Healthcare Roundup —— Sorrento Therapeutics in deal for up to $250M, Moderna submits IND application for Phase 2 COVID-19 study Life Science
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate’s International, Phase III Clinical Study Life Science
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor) Life Science
Healthcare Roundup – Translate Bio jumps 21% on bullish comments from vaccine partner Sanofi, Gilead’s remdesivir trial ahead of schedule Life Science
Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China Life Science
Healthcare Roundup – European regulators on board with Mylan/Upjohn tie-up, BioCryst feels Gilead’s remdesivir pain Life Science
Healthcare Roundup – FDA OKs Immunomedics antibody-drug conjugate for breast cancer, Pfizer and BioNTech on go with COVID-19 vaccine study Life Science
Healthcare Roundup – Liberty Health Sciences updates business amid COVID-19, Atyr Pharma on go with study of lead drug in COVID-19 Life Science
Healthcare Roundup – Another U.S. study points to far higher rate of COVID infection, Money flow spikes in COVID-19 vaccine players amid rush for early data Life Science
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 Life Science
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit Life Science
Healthcare Roundup – U.S. COVID-19 testing capacity still constrained, Sanofi can produce up to 600M doses of COVID-19 vaccine Life Science
